Cloacogenic Carcinoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

Sources

Aliases & Classifications for Cloacogenic Carcinoma

MalaCards integrated aliases for Cloacogenic Carcinoma:

Name: Cloacogenic Carcinoma ¹¹ ¹⁴ ⁷¹

Cloacogenic Anal Carcinoma ¹¹

Classifications:

MalaCards categories:
Global: Cancer diseases
Anatomical: Gastrointestinal diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹¹ DOID:7173

NCIt ⁴⁹ C8255

SNOMED-CT ⁶⁸ 84570003

UMLS ⁷¹ C0334273

Sources

Summaries for Cloacogenic Carcinoma

MalaCards based summary: Cloacogenic Carcinoma, also known as cloacogenic anal carcinoma, is related to basaloid squamous cell carcinoma and neuroendocrine carcinoma. An important gene associated with Cloacogenic Carcinoma is KERA (Keratocan). The drugs Carboplatin and Paclitaxel have been mentioned in the context of this disorder. Affiliated tissues include colon, liver and skin.

Sources

Related Diseases for Cloacogenic Carcinoma

Diseases related to Cloacogenic Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 206)

#	Related Disease	Score	Top Affiliating Genes
1	basaloid squamous cell carcinoma	30.3	SYP KRT5 ENO2
2	neuroendocrine carcinoma	30.1	SYP ENO2
3	basal cell carcinoma	29.8	SYP KRT5 ENO2
4	wilms tumor 1	29.7	SYP KRT5 ENO2
5	rectal cloacogenic carcinoma	11.3
6	anal canal carcinoma	10.5
7	rare tumor	10.3
8	squamous cell carcinoma	10.2
9	rectum cancer	10.2
10	papilloma	10.2
11	transitional cell carcinoma	10.2
12	parietal lobe neoplasm	10.2	KRT5 ENO2
13	vulvar apocrine adenocarcinoma	10.2	KRT5 ENO2
14	spindle cell thymoma	10.1	KRT5 ENO2
15	breast leiomyosarcoma	10.1	KRT5 ENO2
16	olfactory neuroblastoma	10.1	SYP ENO2
17	blastoma	10.1	SYP ENO2
18	malignant melanocytic neoplasm of the peripheral nerve sheath	10.1	SYP ENO2
19	anal neuroendocrine tumor	10.1	SYP ENO2
20	cerebral neuroblastoma	10.1	SYP ENO2
21	neuronal intestinal dysplasia, type b	10.1	SYP ENO2
22	thymus small cell carcinoma	10.1	SYP ENO2
23	gastric small cell carcinoma	10.1	SYP ENO2
24	optic nerve astrocytoma	10.1	SYP ENO2
25	breast neuroendocrine neoplasm	10.1	SYP ENO2
26	pineal region teratoma	10.1	SYP ENO2
27	extraosseous ewings sarcoma-primitive neuroepithelial tumor	10.1	SYP ENO2
28	cauda equina neoplasm	10.1	SYP ENO2
29	colon neuroendocrine neoplasm	10.1	SYP ENO2
30	bile duct mucinous adenocarcinoma	10.1	SYP ENO2
31	ampulla of vater benign neoplasm	10.1	SYP ENO2
32	partial cryptophthalmia	10.1	SYP ENO2
33	carotid body cancer	10.1	SYP ENO2
34	pineal region choriocarcinoma	10.1	SYP ENO2
35	neurohypophysis granular cell tumor	10.1	SYP ENO2
36	granular cell tumor	10.1	SYP ENO2
37	intracranial primitive neuroectodermal tumor	10.1	SYP ENO2
38	cerebellopontine angle primitive neuroectodermal tumor	10.1	SYP ENO2
39	auditory system cancer	10.1	SYP ENO2
40	cerebellar liponeurocytoma	10.1	SYP ENO2
41	nodular ganglioneuroblastoma	10.1	SYP ENO2
42	rectal benign neoplasm	10.1
43	ganglioneuroblastoma	10.1	SYP ENO2
44	frontal lobe neoplasm	10.1	SYP ENO2
45	lipoma of spermatic cord	10.1	SYP ENO2
46	pineocytoma	10.1	SYP ENO2
47	appendix carcinoid tumor	10.1	SYP ENO2
48	urinary bladder small cell neuroendocrine carcinoma	10.1	SYP ENO2
49	jejunal neoplasm	10.1	SYP ENO2
50	melanotic neuroectodermal tumor	10.1	SYP ENO2

Graphical network of the top 20 diseases related to Cloacogenic Carcinoma:

Sources

Symptoms & Phenotypes for Cloacogenic Carcinoma

Sources

Drugs & Therapeutics for Cloacogenic Carcinoma

Drugs for Cloacogenic Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 18)

#

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

1

Carboplatin

Approved

Phase 3

41575-94-4

10339178 38904

2

Paclitaxel

Approved, Vet_approved

Phase 3

33069-62-4

36314

Synonyms:

(2AR-(2aalpha,4b,4abeta,6b,9a(a r*,betas*),11a,12a,12balpha))-b-(benzoylamino)-a-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4b,4abeta,6b,9a(a r*,betas*),11a,12a,12balpha))-b-(benzoylamino)-a-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4β,4abeta,6β,9α(α r*,betas*),11α,12α,12balpha))-β-(benzoylamino)-α-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4β,4abeta,6β,9α(α r*,betas*),11α,12α,12balpha))-β-(benzoylamino)-α-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

5b,20-Epoxy-1,2-a,4,7b,10b,13a-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5b,20-Epoxy-1,2-a,4,7b,10b,13a-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5Β,20-epoxy-1,2-α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5Β,20-epoxy-1,2-α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

7 Epi taxol

7-Epipaclitaxel

7-Epi-paclitaxel

7-epipaclitaxel|Abraxane® (albumin-bound suspension)|Taxol®

7-Epitaxol

7-Epi-taxol

ABI-007

ABRAXANE

Anzatax

BMS 181339-01

BMS-181339-01

Bris taxol

CAPXOL

CYCLOPAX

DHP 107

EBETAXEL

Epitaxol

GENETAXYL

GENEXOL

INTAXEL

LIPOPAC

MBT 0206

MITOTAX

NK 105

NSC-125973

Onxol

PACITAXEL

PACLITAXEL

Paclitaxel, (4 alpha)-isomer

Paxceed

Paxene

PLAXICEL

Praxel

QW-8184

TAXALBIN

TAXOL

TAXOL 100

Taxol a

Taxol, bris

Vascular Wrap

Xorane

YEWTAXAN

3

Nivolumab

Approved

Phase 3

946414-94-4

4

Albumin-Bound Paclitaxel

Phase 3

5

Antimitotic Agents

Phase 3

6

Tubulin Modulators

Phase 3

7

Immune Checkpoint Inhibitors

Phase 3

8

Antineoplastic Agents, Immunological

Phase 3

9

Mitomycin

Approved

Phase 2

50-07-7

5746

10

Cisplatin

Approved

Phase 2

15663-27-1

2767 5702198 441203

11

Fluorouracil

Approved

Phase 2

51-21-8

3385

12

Capecitabine

Approved, Investigational

Phase 2

154361-50-9

60953

Synonyms:

(1-(5-Deoxy-b-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamate pentyl ester

(1-(5-Deoxy-b-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester

(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamate pentyl ester

(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester

(1-(5-Deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamate pentyl ester

(1-(5-Deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester

Capecitabin

Capecitabina

CAPECITABINE

Capécitabine

Capecitabinum

N(4)-Pentyloxycarbonyl-5'-deoxy-5-fluorocytidine

PENTYL [1-(3,4-DIHYDROXY-5-METHYL-OXOLAN-2-YL)-5-FLUORO-2-OXO-PYRIMIDIN-4-YL]AMINOFORMATE

Pentyl [1-(5-deoxy-b-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate

Pentyl [1-(5-deoxy-b-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamic acid

Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate

Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamic acid

Pentyl [1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate

Pentyl [1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamic acid

Pentyl 1-(5-deoxy-b-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate

Pentyl 1-(5-deoxy-b-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamic acid

Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate

Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamic acid

Pentyl 1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate

Pentyl 1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamic acid

R340

RO-091978000

RO-09-1978000

RO-09-1978-000

Ro-09-1978-000|Ro-091978000|Xeloda®

Xeloda

13

Anti-Bacterial Agents

Phase 2

14

Alkylating Agents

Phase 2

15

Antibiotics, Antitubercular

Phase 2

16

Antimetabolites

Phase 2

17

Immunosuppressive Agents

Phase 2

18

Immunologic Factors

Phase 2

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	A Randomized Phase III Study of Immune Checkpoint Inhibition With Chemotherapy in Treatment-Na�ve Metastatic Anal Cancer Patients	Recruiting	NCT04444921	Phase 3	Carboplatin;Paclitaxel
2	A Randomized Phase III Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer	Active, not recruiting	NCT03233711	Phase 3
3	A Randomized Phase II Study De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)	Recruiting	NCT04166318	Phase 2	Capecitabine;Fluorouracil;Mitomycin
4	Risk-Adapted Therapy for HIV-Associated Anal Cancer	Recruiting	NCT04929028	Phase 2	Capecitabine;Fluorouracil;Mitomycin
5	InterAACT - An International Multicentre Open Label Randomised Phase II Advanced Anal Cancer Trial Comparing Cisplatin Plus 5-Fluorouracil Versus Carboplatin Plus Weekly Paclitaxel in Patients With Inoperable Locally Recurrent or Metastatic Disease	Active, not recruiting	NCT02560298	Phase 2	Capecitabine;Carboplatin;Cisplatin;Fluorouracil;Paclitaxel

Search NIH Clinical Center for Cloacogenic Carcinoma

Sources

Genetic Tests for Cloacogenic Carcinoma

Sources

Anatomical Context for Cloacogenic Carcinoma

Organs/tissues related to Cloacogenic Carcinoma:

MalaCards : Colon, Liver, Skin

Sources

Publications for Cloacogenic Carcinoma

Articles related to Cloacogenic Carcinoma:

(show top 50) (show all 117)

#	Title	Authors	PMID	Year
1	A rare case of a superficial squamous cell carcinoma (so-called cloacogenic carcinoma) of the rectum. ⁶²	Tanaka T...Niwa Y	36306057	2022
2	Role of local therapy in the management of patients with metastatic anal squamous cell carcinoma: a National Cancer Database study. ⁶²	Atallah RP...Alese OB	36388688	2022
3	HPV related cloacogenic carcinoma of the anal canal with divergent histomorphology. ⁶²	Gurumurthy RY...Sriram N	31361242	2019
4	Survival rate variation with different histological subtypes of poor prognostic male anal squamous cell carcinoma: a population-based study. ⁶²	Wan Z...Li J	29137429	2017
5	Basaloid Squamous Cell Carcinoma of the Anus Revisited. ⁶²	Graham RP...Lam-Himlin DM	26866355	2016
6	The rising incidence of anal cancer in England 1990-2010: a population-based study. ⁶²	Wilkinson JR...Sebag-Montefiore D	24410872	2014
7	Molecular and immunohistochemical profile of a basaloid (cloacogenic) carcinoma of the sigmoid colon: possible predictive value for clinical outcomes. ⁶²	Gurzu S...Jung I	24584270	2014
8	[Hepatic cyst in a patient with anorectal cloacogenic carcinoma: metastasis or benign liver disease?]. ⁶²	Machado I...Estevan R	22177268	2012
9	What is the clinicopathological characteristic of cloacogenic carcinoma outside the anorectal zone? ⁶²	Akbulut S	21510286	2011
10	FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma. ⁶²	Krengli M...Inglese E	20137093	2010
11	Aggressive treatment approach for cloacogenic carcinoma of the anorectum: report from a single cancer center. ⁶²	Bertani E...Andreoni B	20689291	2010
12	Basaloid (Cloacogenic) Carcinoma Mimicking Intraabdominal Abscess: Report of a Case and Review of the Literature. ⁶²	Akbulut S...Ozmen CA	21103283	2009
13	PNET/Ewing's sarcoma of the rectum: a case report and review of the literature. ⁶²	Aboumarzouk OM...Shorthouse AJ	21691396	2009
14	[Protruding isolated rectal and anal neoplastic polyps removed by local transanal excision: our experience with 16 cases]. ⁶²	Fiducia G...Bosco V	18689170	2008
15	Anal canal carcinoma: experience from a single Korean institution. ⁶²	Lee WS...Park W	17963341	2007
16	Case report of long term survivor of metastatic cloacogenic carcinoma of the anal canal with chemotherapy. ⁶²	Fayaz S...Motawy M	20084726	2007
17	The demographics, histopathology and patterns of treatment of anal cancer in Connecticut: 1980-2000. ⁶²	Hatzaras I...Longo WE	16114640	2005
18	Chemotherapy and radiation of anal canal cancer: the first approach. ⁶²	Eng C...Minsky BD	15137959	2004
19	HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients. ⁶²	Kim JH...Bennett B	11598480	2001
20	Anal carcinoma: a 15-year retrospective analysis. ⁶²	Olofinlade O...Robilotti J	11145292	2000
21	Extrauterine malignancies. Role of Pap smears in diagnosis and management. ⁶²	Gupta D...Balsara G	10518134	1999
22	Cloacogenic adenocarcinoma of the vulva. ⁶²	Willen R...Cajander S	10419750	1999
23	An unusual location of cloacogenic carcinoma. ⁶²	Indinnimeo M...Ghini C	10096758	1998
24	Diagnosis and differential diagnosis of small-cell lesions of the liver. ⁶²	Pisharodi LR...Bedrossian C	9664180	1998
25	[Cancer of the anal canal]. ⁶²	Ruiz Molina JM...Aiello Crocifoglio V	9480525	1997
26	Skin cancers associated with acquired immunodeficiency syndrome. ⁶²	Wang CY...Su WP	7630215	1995
27	Inflammatory cutaneous metastases from cloacogenic carcinoma of the anus. ⁶²	Krasnoff JB...Watsky KL	7633821	1995
28	Transanal excision of rectal carcinoma. ⁶²	Frazee RC...Hendricks JC	7618812	1995
29	[A cloacogenic anal carcinoma in an adolescent]. ⁶²	Carabias A...Moreno Azcoita M	7612375	1995
30	Cloacogenic anal carcinoma presenting with humoral hypercalcemia: report of a case. ⁶²	Nobusawa S...Tanaka N	8640024	1995
31	[Cloacogenic carcinoma with reference to malignant tumors of the anal canal]. ⁶²	Kosugi M...Annen Y	7837635	1994
32	[The prognostic factors following the simultaneous radiochemotherapy of anal canal carcinoma in a multicenter series of 139 patients]. ⁶²	Grabenbauer GG...Wendt T	8052938	1994
33	[Surgical treatment of anorectal disorders in 32 HIV-seropositive patients]. ⁶²	Sars PR...Taat CW	8015620	1994
34	[Perianal basal cell carcinoma. Apropos of 2 cases]. ⁶²	Augey F...Moulin G	7702280	1994
35	[Adenocarcinoma of anal canal. Report of a case and review of the literature]. ⁶²	Pollastri E...Moroni J	7701908	1994
36	[Cloacogenic carcinoma with reference to malignant tumors of the anal canal]. ⁶²	Kosugi M...Annen Y	7736207	1994
37	[Heterotopic cloacogenic carcinoma of the lower lip]. ⁶²	Vulcan P...Grigore M	7979028	1994
38	Irradiation in the management of anal cancer with literature review. ⁶²	Jose BO...Spanos WJ	8320504	1993
39	External radiation therapy without chemotherapy in the management of anal cancer. ⁶²	Martenson JA...Gunderson LL	8448738	1993
40	Perianal basal cell carcinoma. ⁶²	Espana A...Quintanilla E	1458647	1992
41	Surgical treatment of female urethral carcinoma. ⁶²	Narayan P...Konety B	1574827	1992
42	Mixed cloacogenic carcinoma of male urethra. ⁶²	Diaz-Cano SJ...Galera-Davidson H	1737633	1992
43	Cloacogenic carcinoma of the anal canal and associated viral lesions. An in situ hybridization study for human papilloma virus. ⁶²	Aparicio-Duque R...Schinella R	1657356	1991
44	Newer variants and simulants of basal cell carcinoma. ⁶²	Lowe L...Rapini RP	1885825	1991
45	[Spontaneous regression of liver metastases in neuroendocrine tumors of the abdomen]. ⁶²	Christ F...Koch O	2057755	1991
46	Cytokeratin polypeptide expression in a cloacogenic carcinoma and in the normal anal canal epithelium. ⁶²	Levy R...Geiger B	1709765	1991
47	Transitional cloacogenic carcinoma of the female urethra treated with external irradiation and afterloading with cobalt-60. ⁶²	Henriksson C...Johansson SL	2024362	1991
48	Multicentric cloacogenic carcinoma: report of a case with anogenital pruritus at presentation. ⁶²	Lee KC...Muller SA	2229531	1990
49	Neurologic complications of cloacogenic carcinoma. ⁶²	Garofalo M...Masdeu JC	2389732	1990
50	[A case of cloacogenic carcinoma with extra-visceral localization]. ⁶²	Mentasti A...Tagliaferri A	2392255	1990

Sources

Genes for Cloacogenic Carcinoma

Genes related to Cloacogenic Carcinoma (0 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	KERA	Keratocan	Protein Coding	5.16	DISEASES inferred ¹⁴
2	ENO2	Enolase 2	Protein Coding	4.98	DISEASES inferred ¹⁴
3	KRT5	Keratin 5	Protein Coding	4.69	DISEASES inferred ¹⁴
4	SYP	Synaptophysin	Protein Coding	4.64	DISEASES inferred ¹⁴
5	ZNF444	Zinc Finger Protein 444	Protein Coding	4.48	DISEASES inferred ¹⁴
6	SLC45A3	Solute Carrier Family 45 Member 3	Protein Coding	4.36	DISEASES inferred ¹⁴
7	KRT4	Keratin 4	Protein Coding	4.36	DISEASES inferred ¹⁴

Sources

Variations for Cloacogenic Carcinoma

Sources

Expression for Cloacogenic Carcinoma

Search GEO for disease gene expression data for Cloacogenic Carcinoma.

Sources

Pathways for Cloacogenic Carcinoma

Sources

GO Terms for Cloacogenic Carcinoma

Molecular functions related to Cloacogenic Carcinoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	structural constituent of skin epidermis	GO:0030280	8.92	KRT5 KRT4

Sources

Sources for Cloacogenic Carcinoma

¹ BitterDB

² CDC

³ Cell Signaling Technology

⁴ ClinicalTrials

⁵ ClinVar

⁶ CNVD

⁷ Cochrane Library

⁸ Cosmic

⁹ dbSNP

¹⁰ DGIdb

¹¹ Disease Ontology

¹² diseasecard

¹³ DiseaseEnhancer

¹⁴ DISEASES

¹⁵ DrugBank

¹⁶ EFO

¹⁷ ExPASy

¹⁸ FMA

¹⁹ GARD

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ GenomeRNAi

²⁶ GEO DataSets

²⁷ GO

²⁸ GTR

²⁹ HMDB

³⁰ HPO

³¹ ICD10

³² ICD10 via Orphanet

³³ ICD11

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ LifeMap

³⁷ LncRNADisease

³⁸ LOVD

³⁹ MalaCards

⁴⁰ MedGen

⁴¹ MedlinePlus

⁴² MedlinePlus Genetics

⁴³ MeSH

⁴⁴ MESH via Orphanet

⁴⁵ MGI

⁴⁶ miR2Disease

⁴⁷ NCBI Bookshelf

⁴⁸ NCI

⁴⁹ NCIt

⁵⁰ NDF-RT

⁵¹ NIH Clinical Center

⁵² NINDS

⁵³ Novoseek

⁵⁴ Novus Biologicals

⁵⁵ ODiseA

⁵⁶ OMIM via Orphanet

⁵⁷ OMIM® (Updated 08-Dec-2022)

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubChem

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ WikiPathways

⁷⁵ Wikipedia

MCID: CLC003 MIFTS: 26	Cloacogenic Carcinoma Categories: Cancer diseases, Gastrointestinal diseases	Data Licensing For inquiries, contact: [email protected]
Genes Tissues Related diseases Publications Drugs Expand all tables